Prevalence of Amyloidosis in Trauma Patients

Recruiting now

Conditions studied: Amyloidosis

In brief

This study aims to determine the frequency of amyloidosis among patients undergoing trauma surgery.

Key facts

Study ID

NCT06527521

Run by

Consorci Sanitari de l'Alt Penedès i Garraf

People needed

246

Starts

2024-11-13

Expected to finish

2026-10-01

Last updated by the study team

2025-12-02

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women included in the waiting list for scheduled trauma surgery with at least one of the following criteria defined as red flags: Over 65 years old; Possible family history of amyloidosis, Cardiac pathology: aortic stenosis, presence of left ventricular hypertrophy defined as interventricular septal thickness > 12mm measured by echocardiography, history of previous brady- or tachyarrhythmias including cardiac conduction blocks, history of syncope or presyncope, pro BNP > 300 in previous blood tests; History of sensory peripheral neuropathy; History of nephropathy without etiological diagnosis; History of liver disease without a clear cause.
• Ability to cooperate in the necessary evaluations.
• Signed informed consent for inclusion in the study, either by the participant or their legal representative.

You may not qualify if…

• Participants previously diagnosed with amyloidosis cannot be included in the study.

Where it is running

• Consorci Sanitari Alt Penedes i Garraf-Hospital Sant Camil — Sant Pere de Ribes, Barcelona, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.